Skip to main content
. Author manuscript; available in PMC: 2019 Nov 28.
Published in final edited form as: AIDS. 2018 Nov 28;32(18):2777–2786. doi: 10.1097/QAD.0000000000002003

Figure 1: NHL incidence rates by time since ART start in men and women across regions.

Figure 1:

Incidence rates are predicted for adults with a current CD4 cell count of 450 cells/μl who started an NNRTI-based first-line ART regimen between 2008–2014 at the age of 40 years (model 1). ART, antiretroviral therapy; NHL, non-Hodgkin Lymphoma; NNRTI, non-nucleoside reverse-transcriptase inhibitor; pys, person-years.